Can ARA-290 (Cibinetide) and CJC-1295 be stacked together?

Some peptide pairs in different categories (e.g., recovery + cognitive) are commonly stacked. Others overlap mechanistically and should not be combined. Always consult a licensed physician before stacking compounds.

Side-by-side comparison

ARA-290 (Cibinetide) vs CJC-1295

Q: What is the main difference between ARA-290 (Cibinetide) and CJC-1295?

ARA-290 (Cibinetide) is primarily classified as a recovery compound (investigational 11-amino-acid peptide derived from the helix-b region of erythropoietin that activates the innate repair receptor without stimulating red-blood-cell production; studied for small-fiber neuropathy.). CJC-1295 is a performance compound (pairs with ipamorelin for sustained growth hormone spikes, ideal for body comp tweaks.).

ARA-290 (Cibinetide): Investigational 11-amino-acid peptide derived from the helix-B region of erythropoietin that activates the innate repair receptor without stimulating red-blood-cell production; studied for small-fiber neuropathy.

CJC-1295: Pairs with Ipamorelin for sustained growth hormone spikes, ideal for body comp tweaks.

ARA-290 (Cibinetide)

Recovery

Investigational 11-amino-acid peptide derived from the helix-B region of erythropoietin that activates the innate repair receptor without stimulating red-blood-cell production; studied for small-fiber neuropathy.

Top benefits

Activates the innate repair receptor to promote tissue protection and healing
Reduced neuropathic pain symptoms in sarcoidosis small-fiber neuropathy trials
Increased corneal nerve fiber measures (a marker of small-nerve regeneration) without raising hematocrit

Full ARA-290 (Cibinetide) guide→

CJC-1295

Performance

Pairs with Ipamorelin for sustained growth hormone spikes, ideal for body comp tweaks.

Top benefits

Sustained GH release
Improved protein synthesis
Increased muscle mass
Faster recovery

Full CJC-1295 guide→

Attribute	ARA-290 (Cibinetide)	CJC-1295
Category	Recovery	Performance
Type	linear	linear
Chain length	11 aa	29 aa
Formula	helix-B 11-mer (non-erythropoietic EPO derivative)	C152H252N44O42
Common dose	2 mg IV or 1-8 mg SC	100-200 mcg
Frequency	Three times weekly to daily (per trial)	1-2 times daily
Top benefit	Activates the innate repair receptor to promote tissue protection and healing	Sustained GH release
Top side-effect	Generally well tolerated in trials	Water retention

Educational use only

This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.